What changed
Q2 sales hit $12.6B, up 13% reported and 4.8% comparable. GAAP EPS was $0.53, adjusted EPS $1.31. Abbott raised full-year adjusted EPS guidance to $5.45-$5.60 from $5.38-$5.58, while reaffirming comparable sales growth of 6.5%-7.5%. The company returned $2.1B to shareholders via dividends and buybacks.
Why it matters
Q2 sales hit $12.6B, up 13% reported and 4.8% comparable. GAAP EPS was $0.53, adjusted EPS $1.31. Abbott raised full-year adjusted EPS guidance to $5.45-$5.60 from $5.38-$5.58, while reaffirming comparable sales growth of 6.5%-7.5%. The company returned $2.1B to shareholders via dividends and buybacks.